Kavanaugh accuser Christine Blasey Ford, who claims — without any evidence — that Kavanaugh inappropriately touched her at a drunken party while in high school, turns out to have ties to an abortion pill pharmaceutical company called Corcept Therapeutics. This discovery brings to light an obvious conflict of interest in Blasey's story, revealing that she works for a pharmaceutical company that manufacturers an abortion pill drug, whose profits could be strongly impacted by future Supreme Court decisions on abortion rights.
Corcept Therapeutics (Corcept.com) manufacturers and markets an abortion pill drug called mifepristone, and Christine Blasey Ford is a co-author of at least eight published scientific papers produced by the pharmaceutical giant to promote its pills. You can see Blasey's name listed on several publications at this Corcept.com web page detailing their research papers.
Corcept Therapeutics, Inc., a $166 billion market cap company (stock symbol CORT) reportedly has current annual sales of $216 million. The company offers just one drug, mifepristone, which is widely known as an "abortion pill" or RU-486.